Jun 3, 2024 09:15AM
Jun 3, 2024 09:15AM
May 17, 2024 08:00AM
May 14, 2024 06:00PM
May 1, 2024 07:59AM
May 1, 2024 07:55AM
Mar 28, 2024 07:55AM Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris (AEZS)
Mar 28, 2024 07:55AM
Mar 27, 2024 08:05AM
Mar 12, 2024 02:10PM
Feb 26, 2024 07:30AM
Feb 15, 2024 05:50PM
Feb 15, 2024 04:58PM
Dec 14, 2023 07:50AM Aeterna Zentaris (AEZS) and Ceapro Announce Merger of Equals
Dec 14, 2023 07:50AM
Mar 16, 2023 08:11AM
Mar 16, 2023 08:05AM
Jan 11, 2023 01:00PM
May 17, 2021 08:05AM
May 17, 2021 08:05AM
Nov 1, 2018 08:19AM Novo Nordisk A/S (NVO) Acquires Rights to Macrilen in U.S. & Canada from Strongbridge Biopharma (SBBP); Aeterna Zentaris (AEZS) Previously Held Rights
Nov 1, 2018 08:00AM
Nov 1, 2018 08:00AM
Jan 17, 2018 07:01AM
Jan 17, 2018 07:00AM
Nov 28, 2017 09:23AM
Nov 8, 2017 05:05PM
Nov 2, 2017 05:47PM Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017
Sep 25, 2017 04:33PM
Sep 25, 2017 04:30PM
Sep 1, 2017 04:32PM
Sep 1, 2017 04:30PM
Aug 10, 2017 06:09PM
Aug 8, 2017 04:55PM
Aug 8, 2017 04:40PM Aeterna Zentaris Engages Advisors and Provides Update to Shareholders
Aug 4, 2017 05:00PM
Aug 3, 2017 01:26PM
Jul 20, 2017 05:04PM
Jul 20, 2017 05:00PM
Jul 18, 2017 05:02PM
Jul 18, 2017 05:00PM
Jun 30, 2017 09:23AM Aeterna Zentaris (AEZS) Resubmits NDA for Macrilen for Evaluation of AGHD
Jun 30, 2017 09:15AM
Jun 9, 2017 08:30AM
May 9, 2017 04:30PM
May 8, 2017 04:30PM
May 2, 2017 08:30AM
May 1, 2017 09:37AM
May 1, 2017 08:01AM Aeterna Zentaris (AEZS) Phase 3 Study of Zoptrex Doesn't Achieve Primary Endpoint
May 1, 2017 08:00AM

1,160,146 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All